467 results on '"risperidone"'
Search Results
2. Result of tDCS in ASD Children With Comorbidities Like PANDAS, Rare Genetic Diseases or Autoimmune Disorders (tDCS&ASD)
3. The Psychiatric and Cognitive Phenotypes in Velocardiofacial Syndrome (VCFS)
4. Biomarkers of Conversion Risk and Treatment Response in Early-Stage Schizophrenia
5. Pragmatic Trial Comparing Weight Gain in Children With Autism Taking Risperidone Versus Aripiprazole
6. Atypical Antipsychotic-induced Mitochondrial Dysfunction in Patients With Schizophrenia
7. CLOZAPINE Response in Biotype-1
8. Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS) (POPS or POP02)
9. A Clinical Study That Will Assess the Effect of SEP-363856 or Prior Antipsychotic (PA) Standard of Care on Body-weight Associated Parameters in Subjects With Schizophrenia
10. Study to Compare Clozapine vs Treatment as Usual in People With Intellectual Disability & Treatment-resistant Psychosis (CLOZ-AID)
11. Efficacy and Safety of MK-8189 in Participants With an Acute Episode of Schizophrenia (MK-8189-008)
12. Study to Evaluate the Pharmacokinetics (PK) and Safety/Tolerability of Long-Acting Oral LYN-005
13. Pharmacokinetics, Safety and Tolerability of Different Formulations and Dose Strengths of Quarterly Risperidone (QUAR) in Patients With Schizophrenia (QUARTZ)
14. Longitudinal Comparative Effectiveness of Bipolar Disorder Therapies
15. Does Psilocybin Require Psychedelic Effects to Treat Depression? (PSI-RIS)
16. A Study to Evaluate the Ability of Conducting a Study of Oral Risperidone Followed by Paliperidone Palmitate in Rwandan Healthcare Facilities
17. Striatal Connectivity and Clinical Outcome in Psychosis
18. Long-term Antipsychotic Pediatric Safety Trial (LAPS)
19. Risperidone for the Treatment of Huntington's Disease Involuntary Movements
20. KF2022#3-trial: Effect of Tea and Cola Beverage on Absorption of Risperidone Oral Solution (KF2022#3)
21. Synergistic Effect of Vitamin E & D in Reducing Risk of Effects Associated With Atypical Anti-psychotics
22. A Clinical Study That Will Assess How Food Moves Through the Stomach and Effects Blood Glucose Levels in Subjects With Schizophrenia Taking SEP-363856 or and Prior Antipsychotic (PA) Standard
23. Safety and Pharmacokinetics of Antipsychotics in Children 2: Studying TDM in an RCT (SPACe2:STAR)
24. The Characteristics of Treatment Resistant Schizophrenia From the Illness Onset
25. Electrical Brain Stimulation and Pharmacological Treatments in Autism Spectrum Disorder
26. Efficacy and Safety Study of Aripiprazole to Treat Schizophrenia
27. Non-interventional Study of Risperidone ISM® in Schizophrenia Patients Hospitalised Due to a Relapse (RESHAPE)
28. Pharmacokinetic, Safety, and Tolerability Study of Risperidone ISM® at Different Dose Strengths (PRISMA-1)
29. A Trial of the Efficacy and the Safety of RO6889450 (Ralmitaront) vs Placebo in Patients With an Acute Exacerbation of Schizophrenia or Schizoaffective Disorder
30. An Exploratory Analysis of Immune and Inflammatory Response Associated With Clozapine
31. Risk of Breakthrough Symptoms With Long-Acting Injectable Medications
32. "Extended" (Alternate Day) Antipsychotic Dosing
33. Cannabidiol for Treatment of Non-affective Psychosis and Cannabis Use
34. Relationship Between Efficacy of Lumateperone and Brain Glutamate and Dopamine (Lumafep)
35. EFFECT OF RISPERIDONE vs ARIPIPRAZOLE ON OXIDATIVE STRESS IN PATIENTS WITH AUTISM SPECTRUM DISORDER: A RANDOMIZED CONTROLLED TRIAL (versus)
36. Observational Study on the Effect of Switch to Lurasidone in Subjects With Schizophrenia" (SWITCH)
37. Correlation of Genetic Variations With Clinical Response in Substance Use Disorder
38. Study to Evaluate TV-46000 as Maintenance Treatment in Adult and Adolescent Participants With Schizophrenia (RISE)
39. Oral Versus Injectable Risperidone for Treating First-Episode Schizophrenia
40. Safety, Tolerability, and Pharmacokinetics of Switching From Oral Risperidone to Risperidone Implant (DLP-114)
41. Efficacy of Hydroxyzine for Patients With Panic Disorder
42. A Multiple Dose Study to Assess the Safety, Tolerability and PK of Risperidone Extended Release Capsules
43. A Study to Test if TV-46000 is Safe for Maintenance Treatment of Schizophrenia (SHINE)
44. A Safety and PK Study of Injectable Risperidone-SABER and the DosePro Delivery System in Patients With Schizophrenia
45. A Safety Study Comparing LY2140023 to Atypical Antipsychotic Standard Treatment in Schizophrenic Patients
46. Safety and PK Trial With Injectable ZX003 (Risperidone-SABER®) Compared to Risperdal® Consta® in Stable Schizophrenia
47. Is Initial Response to Low Dose Risperidone Predictive for Outcome in Anxiety?
48. Minimizing Doses of Antipsychotic Medication in Older Patients With Schizophrenia.
49. Efficacy of Treatment With Pramipexole or Risperidone in Patients With Refractory Obsessive-compulsive Disorder (OCD) (OCD-RT)
50. Risperidone Treatment In Children With Autism Spectrum Disorder And High Levels Of Repetitive Behavior (ProjectV)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.